NewHa+® Injection Grade Sodium Hyaluronate is supplied as a raw material for pharmaceutical and medical device development. It is intended for technical evaluation and qualification, not as a finished sterile injectable product.
最新的 NewHa+® 规格说明及批次分析证书（COA）示例可为取样或采购前的技术评审提供支持。配方和质量团队可将文件中记载的分子量、固有粘度和关键质量限值，与各自的眼用制剂及目标市场的要求进行对比。.
| 项目 | 详情 |
| 产品名称 | NewHa+® Injection Grade Sodium Hyaluronate |
| CAS号 | 9067-32-7 |
| 年级 | Injection grade raw material |
| Physical form | 白色或白色粉末或纤维聚合体 |
| Assay specification | 95.0–105.0% |
| Bacterial endotoxins | <0.05 IU/mg |
| Microbial contamination | ≤100 cfu/g |
| pH | 5.0–8.5 in a 0.5% solution |
| 分子量 | Reported by batch; reference batch RN20250208-I: 1.09 × 10⁶ Da |
| 特性粘 | Reported by batch; reference batch RN20250208-I: 1.85 m³/kg |
| Reference packaging | 10 g/bag |
| Reference shelf life | 24 months from the manufacturing date |
Injection grade sodium hyaluronate requires a different purchasing review from cosmetic or food grades. Buyers need more than a matching CAS number. Molecular weight, intrinsic viscosity, solution clarity, assay, residual impurities, microbial control and bacterial endotoxins all influence raw-material qualification.
NewHa+® is supplied as a white sodium hyaluronate powder under CAS 9067-32-7. Its specification includes identity testing against the Ph. Eur. reference spectrum, reaction of sodium, solution appearance, pH, assay, protein, nucleic acids, chlorides, heavy metals, iron, residual ethanol, microbial contamination and bacterial endotoxins.
Molecular weight and intrinsic viscosity are reported as batch values rather than fixed acceptance ranges in the available specification. This distinction matters during sourcing. A buyer with a defined rheology, filtration or device-performance target should state the required molecular-weight or intrinsic-viscosity window before sample evaluation.
The product is intended for evaluation by pharmaceutical, medical-device and formulation teams. The supplied powder still requires incoming qualification, process development and final-product controls. The raw-material grade name does not replace sterility testing, finished-product endotoxin assessment, biocompatibility work, stability studies or market-specific regulatory review.
| 外观 | 白色或白色粉末或纤维聚合体 |
| 鉴别 A. 红外线吸收 B。 钠反应 | A. The IR spectrum of the sample exhibits maxima at the same wavelength as that of Ph.Eur. reference spectrum of Sodium Hyaluronate B. It gives reaction of sodium |
| 外观 的解决方案 | 明确和吸光是NMT0.01至600纳米 |
| pH | 5.0-8.5(0.5％的解决方案) |
| 征 粘度 | 报告的测试值 |
| 分子 重量 | 报告的测试值 |
| 核 酸 | 吸光是NMT0.05至260纳米 |
| 蛋白质 | ≤0.05% |
| 氯化物 | ≤0.1% |
| 重金属 | ≤10ppm |
| 铁 | ≤20ppm |
| 干燥损失 | ≤20.0% |
| 测定 | 95.0%-105.0% |
| 残留 溶剂：乙醇 | ≤0.5% |
| 微生物 污染 | ≤100个/克 |
| 细菌 内毒素 | <0 .05 IU/mg |
The example batch has a reported molecular weight of 1.09 × 10⁶ Da and an intrinsic viscosity of 1.85 m³/kg. These are lot-specific results, not permanent limits for every supplied batch. They provide a useful starting point for screening, but the intended product concentration and rheological target must also be considered.
For projects with a defined molecular-weight or intrinsic-viscosity requirement, include the target value, acceptable range and preferred test method in the enquiry. This allows the available material and sample documentation to be reviewed against the same technical basis.
The specification requires a clear solution with absorbance not more than 0.01 at 600 nm. The stated pH range is 5.0–8.5 for a 0.5% solution, while the assay range is 95.0–105.0%. Together, these parameters support identity and quality screening before formulation work begins.
Solution clarity in the raw-material test does not guarantee clarity at the buyer’s final use level. Concentration, mixing conditions, other formulation components and the selected processing route can change the appearance and viscosity of the finished system.
The specification limits nucleic acids, protein, chlorides, heavy metals, iron, residual ethanol and microbial contamination. Bacterial endotoxins are specified at <0.05 IU/mg. These controls are especially relevant when a sodium hyaluronate raw material is being assessed for a regulated product.
The raw-material endotoxin result must not be treated as a finished-product release claim. The applicable final limit and test strategy depend on the product, dose, route of administration and regulatory framework. Buyers should include any method-specific or route-specific acceptance criteria in the technical request.
NewHa+® Injection Grade Sodium Hyaluronate can be evaluated as a raw material in pharmaceutical and medical device development. Molecular weight, intrinsic viscosity, solution clarity, impurity profile and bacterial endotoxin specification should be matched to the intended formulation and processing route.
医药级酸钠的产品可以用作原料或辅助材料的药品或医疗设备用于眼的筹备工作、关节内的准备、手术后的防粘合剂、创伤的愈合外部筹备和软组织填充物和其他医疗产品，其中分为两个指标：眼下降级和注射等级。
| 注射等级 | 弹性，保护角膜细胞 | 粘合剂，用于眼科手术 |
| 润滑性、弹性，促进软骨修复，抑制炎症，缓解痛苦等 | 关节内注射 | |
| 酸钠和其衍生物具有高分子惰性、良好的生物相容性和降解性 | 手术后的防粘合剂、医疗塑料皮肤的化妆品的填充物，组织工程支架的材料 |
NewHa+® Injection Grade
Sodium Hyaluronate can be evaluated as a raw material in pharmaceutical and medical device development. Molecular weight, intrinsic viscosity, solution clarity, impurity profile and bacterial endotoxin specification should be matched to the intended formulation and processing route.
Intra-Articular Formulations
Injection grade sodium hyaluronate is used in the development of sodium hyaluronate-based intra-articular formulations. Define the target concentration, molecular weight, intrinsic viscosity and finished-product rheology before selecting a batch.
Dermal Fillers and Soft-Tissue Products
The material can be assessed as a native sodium hyaluronate starting material or formulation component. Native sodium hyaluronate powder is different from a finished crosslinked gel. Crosslinking, residual reagents, extrusion performance and sterilization require separate process control.
Anti-Adhesion and Other HA-Based Medical Devices
This grade can also be evaluated for hyaluronan-based anti-adhesion products and other medical-device matrices. Raw-material purity, molecular characteristics and microbiological requirements should be matched to the intended device design.
To evaluate product suitability, please provide the intended application, target specifications, estimated quantity, destination market and document requirements.
| Information to Provide | Purpose |
|---|---|
| Intended product and destination market | Define the technical and document requirements |
| Target molecular weight or intrinsic viscosity | Support batch and grade matching |
| Planned concentration | Understand the required viscosity profile |
| Required test items and limits | Check specification compatibility |
| Estimated quantity and packaging | Prepare the sample or quotation |
The published specification provides the initial technical screening criteria. The example COA shows how the defined tests and reported values are presented for one production lot. For an order or qualification sample, use the lot-specific COA for the applicable batch rather than treating an example result as a universal value.
The example document identifies the product, CAS number, batch number, manufacturing date, analysis date, expiry date, packaging, test criteria, results and release conclusion. This gives QA and sourcing teams a traceable starting point for review.
If your project requires a particular document set, list each required document, language and destination market in the enquiry. The current availability and applicable version can then be included in the technical and commercial review.
透明质酸钠广泛存在于人体的玻璃体、关节、脐带、皮肤等部位，是人体中一种不可替代的天然物质。.
透明质酸钠因其独特的源自动体、生物相容性、强大的锁水能力以及粘弹性润滑性，在应用中具有极高的价值。.
医药级透明质酸钠在体内具有保水、润滑关节、促进伤口愈合、抗衰老等重要生理作用。
10g/bottle,100g/bottle, 200g/bottle, 1kg/bag, 5kg/bag, 10kg/bag.
The reference batch is packed at 10 g per bag. State the required quantity, preferred pack size and labelling requirements in the enquiry so these details can be addressed in the quotation.
The example batch carries a 24-month period from manufacturing to expiry. Storage and handling must follow the current product label and applicable safety documentation. Keep the material in its original sealed packaging and protect it from conditions that could compromise powder quality or package integrity.
MOQ, sample quantity and lead time are confirmed with the current quotation. For a useful response, provide the required grade, estimated quantity, project stage, destination country, packaging request and document list.
Renew supports B2B enquiries for NewHa+® Injection Grade Sodium Hyaluronate. The technical review can begin with the example COA and the buyer’s target profile. A sample request should identify the intended product type, required molecular characteristics, test requirements and planned evaluation quantity.
For commercial enquiries, include the estimated annual or project quantity, destination, desired packaging and required delivery window. This helps align the available batch information, document scope and quotation with the intended development program.
No fixed molecular-weight acceptance range appears in the available specification. Molecular weight and intrinsic viscosity are reported by batch. Reference batch RN20250208-I records 1.09 × 10⁶ Da and 1.85 m³/kg. Request the applicable lot result or submit a target range before sample selection.
ZH 
EN 
DE 
KO 
PT 
JA 
ES 
